HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lenalidomide: a new treatment option for Castleman disease.

AuthorsPetr Szturz, Zdeněk Adam, Jana Chovancová, Olga Stehlíková, Martin Klabusay, Zdeněk Rehák, Renata Koukalová, Marta Krejčí, Luděk Pour, Lenka Zahradová, Roman Hájek, Jiří Mayer
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 53 Issue 10 Pg. 2089-91 (Oct 2012) ISSN: 1029-2403 [Electronic] United States
PMID21902577 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide
Topics
  • Antineoplastic Agents (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Castleman Disease (diagnosis, drug therapy)
  • Humans
  • Lenalidomide
  • Lymph Nodes (pathology)
  • Male
  • Middle Aged
  • Multimodal Imaging
  • Positron-Emission Tomography
  • Thalidomide (analogs & derivatives, therapeutic use)
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: